We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
24 hedge funds and large institutions have $5.17M invested in CASI Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 24 → 24 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
1.47% less ownership
Funds ownership: 16.08% → 14.61% (-1.5%)
17% less capital invested
Capital invested by funds: $6.26M → $5.17M (-$1.09M)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
24
Holders Change
–
Holders Change %
0%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$108K |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$35.4K |
| 3 |
Renaissance Technologies
New York
|
+$33.5K |
| 4 |
WSCM
Wellington Shields Capital Management
New York
|
+$16.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.94K |
Top Sellers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$378K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$157K |
| 3 |
B
Bailard
Foster City,
California
|
-$90K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$54.3K |
| 5 |
RC
RBF Capital
San Francisco,
California
|
-$46K |
